The outcomes statement from the August special PBAC meeting reveals the committee largely sticking with the current approach and defaulting to the ongoing discussions on proposed submission process changes.
Latest Video
New Stories
-
Cost of multiple sclerosis in Australia surges as prevalence accelerates
December 3, 2025 - - Latest News -
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 - - Latest News -
Reforming Australia’s Opioid Dependence Treatment Program - From red tape to person-centred care
December 2, 2025 - - Latest News -
Novo Nordisk raises over $106,000 for Type 1 Diabetes research
December 2, 2025 - - Latest News -
Seqirus opens world-class cell-based vaccine and antivenom manufacturing facility
December 2, 2025 - - Latest News -
CLINUVEL advances second therapy toward market with planned 2026 European filing
December 2, 2025 - - Australian Biotech -
Burnt-Out Australians rush to health appointments as year-end pressure peaks
December 2, 2025 - - Other Health
